Innovations in Genicular Outcomes Registry (IGOR): protocol for a real-world registry study of treatments for knee osteoarthritis.
Vinod Dasa, William Mihalko, Adam Rivadeneyra...
https://pubmed.ncbi.nlm.nih.gov/39691173/Actively Recruiting
Led by Pacira Pharmaceuticals, Inc · Updated on 2026-07-23
10000
Participants Needed
19
Research Sites
78 weeks
Total Duration
This research registry collects prospective information on patients managing chronic pain caused by knee osteoarthritis OA or optimizing pain treatment for knee replacement surgery due to knee OA. It aims to gather data on various pain therapies used for OA, including cryo nerve block, radiofrequency ablation RFA, injections like corticosteroids, viscosupplementation, opioids, and other medications such as non-steroidal anti-inflammatory drugs NSAIDs. Participants receive different pain management treatments as part of their care for knee OA, which may include procedures like nerve blocks or injections, or undergo knee arthroplasty if needed. The registry monitors these therapies and treatments over time without assigning specific interventions since it is observational. Throughout the study, participants provide information through questionnaires and medication logs to track pain levels using scales like the Numeric Rating Scale NRS and Brief Pain Inventory-short form BPI-sf, functional status through knee outcome scores, quality of sleep, opioid use, adverse events, patient satisfaction, healthcare utilization, and other health-related quality of life measures. Data collection continues for up to 18 months to observe outcomes and treatment effects over time.
CONDITIONS
Innovations in Genicular Outcomes Registry
K
Kate Fasel, BSN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Pacira Pharmaceuticals, Inc
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 18 months
Participants receive usual care for knee osteoarthritis pain and provide information through questionnaires and medication logs over time.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Vinod Dasa, William Mihalko, Adam Rivadeneyra...
https://pubmed.ncbi.nlm.nih.gov/39691173/Pacira Pharmaceuticals, Inc
Lead Sponsor